Endo Int'l (Nasdaq: ENDP) and Par Pharmaceutical Holdings, Inc., announced that they have entered into a definitive agreement under which ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Hot Corp. News Hot List Hot M&A Management Comments Mergers and Acquisitions Private Equity Spinoffs

Piper Jaffray Raises Price Target on Endo Int'l (ENDP) Leading up to Par Pharma Acquisition May 19, 2015 7:42 AM Endo Int'l (ENDP) Announces FDA Approval of Expanded XIAFLEX LabelMay 18, 2015 6:34 AM Endo to Acquire Par Pharmaceutical, Strategically Expanding Generics Business to a Top 5 Industry LeaderMay 18, 2015 6:30 AM Endo Announces Updated XIAFLEX® Label with Recurrence and Retreatment Data in Patients with Dupuytren's ContractureMay 15, 2015 5:38 PM